This work is licensed under the Creative Commons Attribution 4.0 International License.
Lohmann K, Klein C. Update on the Genetics of Dystonia. Curr Neurol Neurosci Rep. 2017;17(3):26.LohmannKKleinCUpdate on the Genetics of Dystonia20171732610.1007/s11910-017-0735-0Search in Google Scholar
Ozelius LJ, Hewett JW, Page CE, Bressman SB, Kramer PL, Shalish C, de Leon D, Brin MF, Raymond D, Corey DP, Fahn S, Risch NJ, Buckler AJ, Gusella JF, Breakefield XO. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet. 1997;17(1):40-48.OzeliusLJHewettJWPageCEBressmanSBKramerPLShalishCde LeonDBrinMFRaymondDCoreyDPFahnSRischNJBucklerAJGusellaJFBreakefieldXOThe early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein1997171404810.1038/ng0997-40Search in Google Scholar
Granata A, Warner TT. The role of torsinA in dystonia. Eur J Neurol. 2010;17 Suppl 1:81-87.GranataAWarnerTTThe role of torsinA in dystonia201017 Suppl1818710.1111/j.1468-1331.2010.03057.xSearch in Google Scholar
Atai NA, Ryan SD, Kothary R, Breakefield XO, Nery FC. Untethering the nuclear envelope and cytoskeleton: biologically distinct dystonias arising from a common cellular dysfunction. Int J Cell Biol. 2012;2012:634214.AtaiNARyanSDKotharyRBreakefieldXONeryFCUntethering the nuclear envelope and cytoskeleton: biologically distinct dystonias arising from a common cellular dysfunction2012201263421410.1155/2012/634214Search in Google Scholar
Jokhi V, Ashley J, Nunnari J, Noma A, Ito N, WakabayashiIto N, Moore MJ, Budnik V. Torsin mediates primary envelopment of large ribonucleoprotein granules at the nuclear envelope. Cell Rep. 2013;3(4):988-995.JokhiVAshleyJNunnariJNomaAItoNWakabayashiItoNMooreMJBudnikVTorsin mediates primary envelopment of large ribonucleoprotein granules at the nuclear envelope20133498899510.1016/j.celrep.2013.03.015Search in Google Scholar
Worman HJ, Dauer WT. The nuclear envelope: an intriguing focal point for neurogenetic disease. Neurotherapeutics. 2014;11(4):764-772.WormanHJDauerWTThe nuclear envelope: an intriguing focal point for neurogenetic disease201411476477210.1007/s13311-014-0296-8Search in Google Scholar
Warner TT, Granata A, Schiavo G. TorsinA and DYT1 dystonia: a synaptopathy? Biochem Soc Trans. 2010;38(2):452-456.WarnerTTGranataASchiavoGTorsinA and DYT1 dystonia: a synaptopathy?201038245245610.1042/BST0380452Search in Google Scholar
Kakazu Y, Koh JY, Ho KW, Gonzalez-Alegre P, Harata NC. Synaptic vesicle recycling is enhanced by torsinA that harbors the DYT1 dystonia mutation.Synapse. 2012;66(5):453-464.KakazuYKohJYHoKWGonzalez-AlegrePHarataNCSynaptic vesicle recycling is enhanced by torsinA that harbors the DYT1 dystonia mutation201266545346410.1002/syn.21534Search in Google Scholar
Yokoi F, Cheetham CC, Campbell SL, Sweatt JD, Li Y. Pre-synaptic release deficits in a DYT1 dystonia mouse model. PLoS One. 2013;8(8):e72491.YokoiFCheethamCCCampbellSLSweattJDLiYPre-synaptic release deficits in a DYT1 dystonia mouse model201388e7249110.1371/journal.pone.0072491Search in Google Scholar
McLean PJ, Kawamata H, Shariff S, Hewett J, Sharma N, Ueda K, Breakefield XO, Hyman BT. TorsinA and heat shock proteins act as molecular chaperones: suppression of alphasynuclein aggregation. J Neurochem. 2002;83(4):846-854.McLeanPJKawamataHShariffSHewettJSharmaNUedaKBreakefieldXOHymanBTTorsinA and heat shock proteins act as molecular chaperones: suppression of alphasynuclein aggregation200283484685410.1046/j.1471-4159.2002.01190.xSearch in Google Scholar
Caldwell GA, Cao S, Sexton EG, Gelwix CC, Bevel JP, Caldwell KA. Suppression of polyglutamine-induced protein aggregation in Caenorhabditis elegans by torsin proteins. Hum Mol Genet. 2003;12(3):307-319.CaldwellGACaoSSextonEGGelwixCCBevelJPCaldwellKASuppression of polyglutamine-induced protein aggregation in Caenorhabditis elegans by torsin proteins200312330731910.1093/hmg/ddg027Search in Google Scholar
Burdette AJ, Churchill PF, Caldwell GA, Caldwell KA. The early-onset torsion dystonia-associated protein, torsinA, displays molecular chaperone activity in vitro. Cell Stress Chaperones. 2010;15(5):605-617.BurdetteAJChurchillPFCaldwellGACaldwellKAThe early-onset torsion dystonia-associated protein, torsinA, displays molecular chaperone activity in vitro201015560561710.1007/s12192-010-0173-2Search in Google Scholar
Labbadia J, Morimoto RI. Huntington’s disease: underlying molecular mechanisms and emerging concepts. Trends Biochem Sci. 2013;38(8):378-385.LabbadiaJMorimotoRIHuntington’s disease: underlying molecular mechanisms and emerging concepts201338837838510.1016/j.tibs.2013.05.003Search in Google Scholar
Milewski M, Gawliński P, Bąk D, Matysiak A, Bal J. Complex interplay between the length and composition of the huntingtin-derived peptides modulates the intracellular behavior of the N-terminal fragments of mutant huntingtin. Eur J Cell Biol. 2015;94(5):179-189.MilewskiMGawlińskiPBąkDMatysiakABalJComplex interplay between the length and composition of the huntingtin-derived peptides modulates the intracellular behavior of the N-terminal fragments of mutant huntingtin201594517918910.1016/j.ejcb.2015.02.001Search in Google Scholar
Naismith TV, Heuser JE, Breakefield XO, Hanson PI. TorsinA in the nuclear envelope. Proc Natl Acad Sci USA. 2004;101(20):7612-7617.NaismithTVHeuserJEBreakefieldXOHansonPITorsinA in the nuclear envelope2004101207612761710.1073/pnas.0308760101Search in Google Scholar
Zolkiewski M, Zhang T, Nagy M. Aggregate reactivation mediated by the Hsp100 chaperones. Arch Biochem Biophys. 2012;520(1):1-6.ZolkiewskiMZhangTNagyMAggregate reactivation mediated by the Hsp100 chaperones201252011610.1016/j.abb.2012.01.012Search in Google Scholar
Li X, Lee J, Parsons D, Janaurajs K, Standaert DG. Evaluation of TorsinA as a target for Parkinson disease therapy in mouse models. PLoS One. 2012;7(11):e50063.LiXLeeJParsonsDJanaurajsKStandaertDGEvaluation of TorsinA as a target for Parkinson disease therapy in mouse models2012711e5006310.1371/journal.pone.0050063Search in Google Scholar
Williams AJ, Paulson HL. Polyglutamine neurodegeneration: protein misfolding revisited. Trends Neurosci. 2008;31(10):521528.WilliamsAJPaulsonHLPolyglutamine neurodegeneration: protein misfolding revisited2008311052152810.1016/j.tins.2008.07.004Search in Google Scholar
Hoffner G, Djian P. Polyglutamine Aggregation in Huntington Disease: Does Structure Determine Toxicity? Mol Neurobiol. 2015;52(3):1297-1314.HoffnerGDjianPPolyglutamine Aggregation in Huntington Disease: Does Structure Determine Toxicity?20155231297131410.1007/s12035-014-8932-1Search in Google Scholar
Bak D, Milewski M. The composition of the polyglutaminecontaining proteins influences their co-aggregation properties. Cell Biol Int. 2010;34(9):933-942.BakDMilewskiMThe composition of the polyglutaminecontaining proteins influences their co-aggregation properties201034993394210.1042/CBI20090474Search in Google Scholar
Kuiper EF, de Mattos EP, Jardim LB, Kampinga HH, Bergink S. Chaperones in Polyglutamine Aggregation: Beyond the Q-Stretch. Front Neurosci. 2017;11:145.KuiperEFde MattosEPJardimLBKampingaHHBerginkSChaperones in Polyglutamine Aggregation: Beyond the Q-Stretch20171114510.3389/fnins.2017.00145Search in Google Scholar
Gonzalez-Alegre P, Paulson HL. Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia. J Neurosci. 2004;24(11):2593-2601.Gonzalez-AlegrePPaulsonHLAberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia200424112593260110.1523/JNEUROSCI.4461-03.2004Search in Google Scholar
Chiti F, Dobson CM. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. Annu Rev Biochem. 2017;86:27-68.ChitiFDobsonCMProtein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade201786276810.1146/annurev-biochem-061516-045115Search in Google Scholar